Abiraterone pharmacokinetics were characterized by an extensive apparent clearance , which was lower in patients with mCRPC ( 1,550 L/h ) versus healthy subjects ( 2,240 L/h ) , and by large apparent central ( 5,620 L ) and peripheral ( 17,400 L ) volumes of distribution .